Literature DB >> 30288147

Best of the 2018 AUA Annual Meeting.

Zeyad R Schwen1, Alan W Partin1.   

Abstract

Keywords:  Active surveillance; Prostate cancer; Risk stratification; mpMRI

Year:  2018        PMID： 30288147      PMCID： PMC6168331          DOI： 10.3909/riu0806

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  11 in total

1.  Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Authors:  Stefano Luzzago; Gennaro Musi; Michele Catellani; Andrea Russo; Ettore Di Trapani; Francesco Alessandro Mistretta; Roberto Bianchi; Gabriele Cozzi; Andrea Conti; Paola Pricolo; Matteo Ferro; Deliu-Victor Matei; Vincenzo Mirone; Giuseppe Petralia; Ottavio de Cobelli
Journal:  Urol Int       Date:  2018-05-07       Impact factor: 2.089

2.  Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population.

Authors:  Win Shun Lai; Jennifer B Gordetsky; John V Thomas; Jeffrey W Nix; Soroush Rais-Bahrami
Journal:  Cancer       Date:  2017-01-31       Impact factor: 6.860

3.  Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

Authors:  Stacy Loeb; Nataliya Byrne; Danil V Makarov; Herbert Lepor; Dawn Walter
Journal:  JAMA       Date:  2018-06-05       Impact factor: 56.272

4.  Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer.

Authors:  David Thurtle; Tristan Barrett; Vineetha Thankappan-Nair; Brendan Koo; Anne Warren; Christof Kastner; Kasra Saeb-Parsy; Jenna Kimberley-Duffell; Vincent J Gnanapragasam
Journal:  BJU Int       Date:  2018-03-08       Impact factor: 5.588

5.  Reclassification rates are higher among African American men than Caucasians on active surveillance.

Authors:  Debasish Sundi; Farzana A Faisal; Bruce J Trock; Patricia K Landis; Zhaoyong Feng; Ashley E Ross; H Ballentine Carter; Edward M Schaeffer
Journal:  Urology       Date:  2014-10-14       Impact factor: 2.649

Review 6.  Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review.

Authors:  Ivo G Schoots; Neophytos Petrides; Francesco Giganti; Leonard P Bokhorst; Antti Rannikko; Laurence Klotz; Arnauld Villers; Jonas Hugosson; Caroline M Moore
Journal:  Eur Urol       Date:  2014-11-15       Impact factor: 20.096

7.  The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry.

Authors:  Mahesha Weerakoon; Nathan Papa; Nathan Lawrentschuk; Sue Evans; Jeremy Millar; Mark Frydenberg; Damien Bolton; Declan G Murphy
Journal:  BJU Int       Date:  2015-04       Impact factor: 5.588

8.  Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

Authors:  Jeffrey J Tosoian; Mufaddal Mamawala; Jonathan I Epstein; Patricia Landis; Sacha Wolf; Bruce J Trock; H Ballentine Carter
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

9.  Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.

Authors:  Stacy Loeb; Yasin Folkvaljon; Caitlin Curnyn; David Robinson; Ola Bratt; Pär Stattin
Journal:  JAMA Oncol       Date:  2017-10-01       Impact factor: 31.777

10.  Multi-institution analysis of racial disparity among African-American men eligible for prostate cancer active surveillance.

Authors:  Michael Dinizo; Weichung Shih; Young Suk Kwon; Daniel Eun; Adam Reese; Laura Giusto; Edouard J Trabulsi; Bertram Yuh; Nora Ruel; Daniel Marchalik; Jonathan Hwang; Shilajit D Kundu; Scott Eggener; Isaac Yi Kim
Journal:  Oncotarget       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.